Recent News
Feb 3, 2026 — A Pomerantz LLP investor alert announced an investigation into potential claims on behalf of Northrim investors. Feb 20, 2026 — Brean Capital resumed coverage with a BUY rating and a $31.00 price target, citing above‑peer net interest margin and favorable loan/deposit growth expectations.
Technical Analysis
Directional indicators convey low conviction: ADX at 12.74 signals no established trend, reducing the reliability of directional signals for short-term moves.
DI+ shows a dip-and-reversal (bullish), while DI- shows a dip-and-reversal (bearish); the concurrent dip-and-reversals signal directional conflict rather than a clean trending bias.
MACD sits slightly positive at 0.26 with the MACD above its 0.25 signal line—this crossover represents a short-term bullish signal—but the MACD trend shows a peak-and-reversal, indicating bearish momentum pressure beneath the crossover.
MRO at -5.98 indicates the price sits below the WMDST target and therefore carries upward potential toward fair value; that potential coexists with the MRO peak-and-reversal signature, which tempers conviction in sustained rapid appreciation.
RSI at 51.87 remains essentially neutral; the RSI peak-and-reversal suggests momentum has waned from a recent high and may consolidate near current levels.
Price behavior vs averages supports a mild constructive bias: close $24.73 sits above the 200‑day average ($23.77) and essentially at the 20‑day average ($24.68), placing the stock inside the 1‑standard‑deviation Bollinger band range ($24.26–$25.10). Volume at 76,262 trails 10/50/200‑day averages, indicating moves lack strong participation and increasing the chance of rangebound action.
Fundamental Analysis
Q1 2026 operating results show EPS $0.61 vs. estimate $0.53, a 15.09% EPS surprise; net income totaled $13.7 million for the quarter. The company recorded a provision for credit losses of $0.96 million and reported portfolio loans of approximately $2.36 billion.
Profitability and growth metrics: reported earnings growth stands at 12.96%, while earnings growth QoQ equals -154.14% and earnings growth YoY equals -54.51% as reported; revenue growth reads 25.77% overall, with QoQ revenue growth of 5.04% and YoY revenue growth of 5.97%.
Valuation multiples: trailing P/E at 39.65 and forward P/E at 35.05. The trailing P/E sits above the industry peer median of 35.35 but below the industry peer mean of 53.00. PEG stands at 3.06, above the industry peer mean of -8.70 and above the industry peer median of -21.36; the industry peer range for PEG spans -41.41 to 36.24.
Capital and funding: tangible book value per share rose to $12.81 and book value per share to $15.10 at quarter end. Invested capital shows a reported negative balance of $-500,345,000. Cost of debt registers at 13.61%, and cash‑flow‑to‑earnings reads 0.0, indicating cash conversion metrics that warrant monitoring relative to interest expense and funding mix.
WMDST values the stock as fair-valued based on the compiled multiples, earnings profile, and current balance-sheet parameters.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-22 |
| NEXT REPORT DATE: | 2026-07-22 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.53 | |
| EPS Actual | $ 0.61 | |
| EPS Difference | $ 0.08 | |
| EPS Surprise | 15.094 % | |
| Forward EPS | $ 0.69 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 39.647 | |
| Price To Earnings QoQ | -17.419 % | |
| Price To Earnings YoY | 30.998 % | |
| Price To Earnings IPRWA | high: 85.229 mean: 53.002 NRIM: 39.647 median: 35.349 low: 28.296 |
|
| PE/G Ratio | 3.058 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 35.047 | |
| Forward PE/G | 2.704 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -500.35 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 13.606 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 25.765 % | |
| Revenue Growth QoQ | 504.245 % | |
| Revenue Growth YoY | 596.54 % | |
| Revenue Growth IPRWA | NRIM: 25.765 % high: 20.29 % mean: 10.203 % median: -2.28 % low: -11.349 % |
|
| Earnings Growth | 12.963 % | |
| Earnings Growth QoQ | -154.139 % | |
| Earnings Growth YoY | -54.511 % | |
| Earnings Growth IPRWA | high: 41.86 % NRIM: 12.963 % mean: -5.579 % median: -13.953 % low: -43.519 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |